175 related articles for article (PubMed ID: 1499083)
1. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
Standeven AM; Wetterhahn KE
Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
[TBL] [Abstract][Full Text] [Related]
2. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates.
Standeven AM; Wetterhahn KE
Carcinogenesis; 1991 Sep; 12(9):1733-7. PubMed ID: 1893533
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
[TBL] [Abstract][Full Text] [Related]
4. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of chromium(VI) and chromium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA.
Hneihen AS; Standeven AM; Wetterhahn KE
Carcinogenesis; 1993 Sep; 14(9):1795-803. PubMed ID: 8403202
[TBL] [Abstract][Full Text] [Related]
6. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
[TBL] [Abstract][Full Text] [Related]
7. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
Tsou TC; Lai HJ; Yang JL
Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
[TBL] [Abstract][Full Text] [Related]
8. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
Quievryn G; Messer J; Zhitkovich A
Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
10. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro.
Stearns DM; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):21-5. PubMed ID: 7843100
[TBL] [Abstract][Full Text] [Related]
11. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol.
Carlisle DL; Pritchard DE; Singh J; Owens BM; Blankenship LJ; Orenstein JM; Patierno SR
Toxicol Sci; 2000 May; 55(1):60-8. PubMed ID: 10788560
[TBL] [Abstract][Full Text] [Related]
13. Pathways of Cr (III) and Cr (VI) in the rat after intratracheal administration.
Edel J; Sabbioni E
Hum Toxicol; 1985 Jul; 4(4):409-16. PubMed ID: 4018821
[TBL] [Abstract][Full Text] [Related]
14. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
Morse JL; Luczak MW; Zhitkovich A
Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
[TBL] [Abstract][Full Text] [Related]
15. Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro.
Capellmann M; Bolt HM
Arch Toxicol; 1992; 66(1):45-50. PubMed ID: 1580793
[TBL] [Abstract][Full Text] [Related]
16. Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics.
Luczak MW; Green SE; Zhitkovich A
Environ Health Perspect; 2016 Jan; 124(1):61-6. PubMed ID: 25977998
[TBL] [Abstract][Full Text] [Related]
17. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
O'Brien T; Mandel HG; Pritchard DE; Patierno SR
Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
[TBL] [Abstract][Full Text] [Related]
18. Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels.
Reynolds M; Armknecht S; Johnston T; Zhitkovich A
Mutagenesis; 2012 Jul; 27(4):437-43. PubMed ID: 22241526
[TBL] [Abstract][Full Text] [Related]
19. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
[TBL] [Abstract][Full Text] [Related]
20. In vitro reduction of Cr(VI) by low molecular weight biomimetic components: a comparative study using UV-Vis spectroscopy.
Kaiwar SP; Rao CP
Chem Biol Interact; 1995 Mar; 95(1-2):89-96. PubMed ID: 7697756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
